Paul Sagan, Director at Moderna, Inc. (MRNA), bought 63,240 shares at $31.76 ($2.0M) on 2025-03-03, disclosed to the SEC on 2025-03-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.76 | 31,620 | $1.0M | 50.0% |
| 2 | $31.76 | 31,620 | $1.0M | 50.0% |
| Total | $31.76 avg | 63,240 | $2.0M | 100% |
| Filing → |
| AKAM | SELL | 2018-11-09 | $7.8M | — | Filing → |
| AKAM | SELL | 2018-08-08 | $5.9M | — | Filing → |
| AKAM | SELL | 2018-07-26 | $3.1M | — | Filing → |